Beta Drugs (NSE:BETA) Other Operating Expense : ₹779 Mil (TTM As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Beta Drugs Other Operating Expense?

Beta Drugs's Other Operating Expense for the six months ended in Sep. 2024 was ₹433 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 was ₹779 Mil.

Beta Drugs's quarterly Other Operating Expense increased from Sep. 2023 (₹297 Mil) to Mar. 2024 (₹347 Mil) and increased from Mar. 2024 (₹347 Mil) to Sep. 2024 (₹433 Mil).

Beta Drugs's annual Other Operating Expense increased from Mar. 2022 (₹315 Mil) to Mar. 2023 (₹486 Mil) and increased from Mar. 2023 (₹486 Mil) to Mar. 2024 (₹565 Mil).

Beta Drugs Other Operating Expense Historical Data

The historical data trend for Beta Drugs's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beta Drugs Other Operating Expense Chart

Beta Drugs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Operating Expense

Get a 7-Day Free Trial

193.68

231.25

314.85

486.48

565.39

Beta Drugs Semi-Annual Data
	Mar13	Mar14	Mar15	Mar16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Other Operating Expense	Get a 7-Day Free Trial															252.21	293.57	297.19	346.63	432.55

Beta Drugs Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹779 Mil.

Beta Drugs Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Beta Drugs's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Beta Drugs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beta Drugs Ltd (NSE:BETA) » Definitions » Other Operating Expense

Traded in Other Exchanges

N/A

Address

SCO-184, First Floor, Sector-5, Panchkula, HR, IND, 134114

Website

https://www.betadrugslimited.com

Beta Drugs Ltd operates in the pharmaceutical industry. The company manufactures and sells Oncology products in the form of tablets, capsules, oral formulations, and injections. It sells the products in India and also exports them to other countries of which key revenue is derived from the sales made in India.

Beta Drugs Headlines

No Headlines